Corrigendum to “Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives” [Bioorg. Med. Chem. 15 (2007) 2434–2440] (S0968089607000259) (10.1016/j.bmc.2007.01.016));Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 6, 2007, Pages 2434-2440

  Metwally, Kamel ^a   Aly, Omar ^b   Aly, Enayat ^c   Banerjee, Abhijit ^d   Ravindra, Rudravajhala ^d   Bane, Susan ^d  

^a Zagazig University   (Egypt)

^b MINIA UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d BINGHAMTON UNIVERSITY   (United States)

Author keywords

Cytotoxic agents; Pyrimido 4,5 c quinolin 1(2H) ones; Tubulin polymerization

Indexed keywords

2 (2 BROMOPHENYL) 5 (4 BROMOPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 2 (2 BROMOPHENYL) 5 (4 CHLOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 2 (2 CHLOROPHENYL) 5 (4 CHLOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 2 (3 BROMOPHENYL) 5 (4 BROMOPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 2 (3 BROMOPHENYL) 5 (4 CHLOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 2 (3 CHLOROPHENYL) 5 (4 CHLOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 2 (4 BROMOPHENYL) 5 (4 CHLOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 2,5 BIS(4 BROMOPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 2,5 BIS(4 CHLOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 BROMOPHENYL) 2 (2 METHOXYPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 BROMOPHENYL) 2 (2 METHYLPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 BROMOPHENYL) 2 (3 CHLOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 BROMOPHENYL) 2 (4 CHLOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 BROMOPHENYL) 2 (4 FLUOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 BROMOPHENYL) 2 (4 METHOXYPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 BROMOPHENYL) 2 (4 METHYLPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 BROMOPHENYL) 3 METHYL 2 PHENYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 CHLOROPHENYL) 2 (2 METHOXYPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 CHLOROPHENYL) 2 (2 METHYLPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 CHLOROPHENYL) 2 (4 FLUOROPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 CHLOROPHENYL) 2 (4 METHOXYPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 CHLOROPHENYL) 2 (4 METHYLPHENYL) 3 METHYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; 5 (4 CHLOROPHENYL) 3 METHYL 2 PHENYLPYRIMIDO[4,5 C]QUINOLIN 1(2H) ONE; ANTINEOPLASTIC AGENT; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; MICROTUBULE ASSEMBLY; SUBSTITUTION REACTION;

EID: 33846897220     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2017.03.025     Document Type: Erratum

References (22)

1. Ambudkar S., Dey S., Hrycyna C., Ramachandra M., Pastan I., and Gottesman M. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 361-368
2. Rowinsky E. Annu. Rev. Med. 48 (1997) 353-374
3. Goa K., and Faulds D. Drugs Aging 5 (1994) 200-234
4. Lai Y., Huang L., Lee K., Xiao Z., Bastow K., Yamori T., and Kuo S. Bioorg. Med. Chem. 13 (2005) 265-275
5. Kuo S., Lee H., Juang J., Lin Y., Wu T., Chang J., Lednicer D., Paull K., Lin C., Hamel E., and Lee K. J. Med. Chem. 36 (1993) 1146-1156
6. Li L., Wang H., Kuo S., Wu T., Mauger A., Lin C., Hamel E., and Lee K.H. J. Med. Chem. 37 (1994) 3400-3407
7. Ferlin M., Chiarelotto G., Gasparotto V., Via L., Pezzi V., Barzon L., Palu G., and Castagliuolo I. J. Med. Chem. 48 (2005) 3417-3427
8. Li L., Wang H., Kuo S., Wu T., Lednicer D., Lin C., Hamel E., and Lee K.H. J. Med. Chem. 37 (1994) 1126-1135
9. Xia Y., Yang Z., Xia P., Bastow K., Tachibana Y., Kuo S., Hamel E., Hackl T., and Lee K. J. Med. Chem. 41 (1998) 1155-1162
10. Xia Y., Yang Z., Xia P., Hackl T., Hamel E., Mauger A., Wu J., and Lee K. J. Med. Chem. 44 (2001) 3932-3936
11. Zhao Y., Chen Y., Chang F., and Tzeng C. Eur. J. Med. Chem. 40 (2005) 792-797
12. Chen Y., Huang C., Huang Z., Tseng C., Chang F., Yang S., Lin S., and Tzeng C. Bioorg. Med. Chem. 14 (2006) 3098-3105
13. Peczynska-Czoch W., Pognan F., Kaczmarek L., and Boratynski J. J. Med. Chem. 37 (1994) 3503-3510
14. Chen Y., Hung H., Lu C., Li K., and Tzeng C. Bioorg. Med. Chem. 12 (2004) 6539-6546
15. Chen Y., Chung C., Chen I., Chen P., and Jeng H. Bioorg. Med. Chem. 10 (2002) 2705-2712
16. Katoen-Chackal S., Facompre M., Houssin R., Pommery N., Goossens J., Colson P., Bailly C., and Henichart J. J. Med. Chem. 47 (2004) 3665-3673
17. Metwally, K.; Pratsinis, H.; Kletsas, D. Eur. J. Med. Chem., in press.
18. Poletto, J.; Westwood, N.; Powell, D.; Valley Cottage, N.; Boschelli, D.; Novi, M. US patent, 4,968,702 1990.
19. Pfitzinger W. J. Prakt. Chem. 33 (1886) 100-105
20. Cifuentes M., Schilling B., Ravindra R., Winter J., and Janik M.E. Bioorg. Med. Chem. Lett. 16 (2006) 2761-2764
21. Chang M., Uang B., Wu H., Lee J., Hahn L., and Jeng J. Br. J. Pharmacol. 135 (2002) 619-630
22. Barron D.M., Chatterjee S.K., Ravindra R., Roof R., Baloglu E., Kingston D.G., and Bane S. Anal. Biochem. 315 (2003) 49-56